Cidara Therapeutics Sheds Skin, Shifts To Immunotherapy
Seeking Alpha,
Follow Summary Cidara Therapeutics is a biotechnology company developing rezafungin, a long-acting echinocandin antifungal drug…
MIL-Evening Report: Explainer: what is Candida Auris and who is at risk?
Foreign Affairs New Zealand,
Source: The Conversation (Au and NZ) – By Monica Slavin, Head, Department Infectious Diseases, Peter MacCallum Cancer Centre…
what is Candida Auris and who is at risk?
The Conversation,
We’ve recently heard a lot about Candida auris, a deadly, antibiotic-resistant fungus emerging around the world.
CDC warns of drug-resistant yeast infection
Mass Live,
"Given the occurrence of C. auris in nine countries on four continents since 2009, CDC is alerting U.S.